La chaîne d'options affiche les données clés des options sur actions de Honest Co à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Honest Co..

Honest Co (NASDAQ:HNST) Stock, Chaîne d'Options

HONEST CO INC/THE

Honest Co

The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

The Honest Co Inc

Feasibility endpoint achieved; rapid Ki‑67 suppression and substantial MRI‑confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4427161-1&amp;h=1470666501&amp;u=https%3A%2F%2Fatossatherapeutics.com%2F&amp;a=Atossa+Therapeutics%2C+Inc.">Atossa Therapeutics, Inc.</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATOS#NASDAQ">ATOS</a>) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today reported full results from the Phase 2 Endocrine Optimization Pilot (EOP) sub‑study within the I‑SPY 2 TRIAL evaluating low‑dose oral (Z)‑endoxifen (10 mg daily) as a neoadjuvant treatment in 20 women with stage II/III estrogen‑receptor–positive (ER+), HER2‑negative breast cancer.

News

ATOS

Atossa Therapeutics Reports Full Results From Phase 2 EOP Sub‑Study Within I‑SPY 2 Trial Evaluating Low‑Dose Oral (Z)‑Endoxifen As Neoadjuvant Treatment In 20 Women With Stage II/III ER+, HER2‑Negative Breast Cancer

Millrose Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRP#NYSE">MRP</a>) reported quarterly earnings of $0.39 per share.

Earnings

Millrose Properties Q1 EPS $0.39

Antalpha Platform Holding Company ("Antalpha" or the "Company") today announced the pricing of its initial public offering of 3,850,000 ordinary shares at a price to the public of $12.80 per ordinary share. The ordinary shares have been approved for listing and are expected to begin trading on the Nasdaq Global Market on May 14, 2025, under the ticker symbol "ANTA." The offering is expected to close on May 15, 2025, subject to customary closing conditions.
Antalpha has granted the underwriters a 30-day option to purchase an additional 577,500 ordinary shares to cover over-allotments in connection with the offering.

IPOs

ANTA

Antalpha Announces Pricing Of Initial Public Offering Of 3.85M Shares At A Price Of $12.80 Per Share

Citigroup analyst Arthur Truslove downgrades UL Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULS#NYSE">ULS</a>) from Buy to Neutral and raises the price target from $60.5 to $71.

Downgrades

Price Target

Analyst Ratings

Citigroup Downgrades UL Solutions to Neutral, Raises Price Target to $71

IO Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.38) by 10.53 percent. This is a 13.33 percent decrease over losses of $(0.30) per share from the same period last year.

Earnings Beats

IOBT

IO Biotech Q1 EPS $(0.34) Beats $(0.38) Estimate

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the communication services sector.
<h3 class="wp-block-heading">Shutterstock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSTK#NYSE">SSTK</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.83%</li>
<li>JMP Securities analyst Andrew Boone reiterated a Market Perform rating on May 5, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Needham analyst Bernie McTernan maintained a Buy rating and cut the price target from $45 to $30 on March 7, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 2, the company posted downbeat quarterly results</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514">SSTK news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514"><img loading="lazy" decoding="async" width="896" height="811" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156.png" alt="" class="wp-image-914631" style="width:590px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156.png 896w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044751/image-156-768x695.png 768w" sizes="(max-width: 896px) 100vw, 896px" /></a></figure>
<h3 class="wp-block-heading">Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.35%</li>
<li>Tigress Financial analyst Ivan Feinseth maintained a Buy rating and raised the price target from $55 to $56 on April 28, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Scotiabank analyst Maher Yaghi maintained a Sector Perform rating and increased the price target from $48.5 to $49 on April 23, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On May 13, Verizon announced a $5 billion commitment to continue investing in America and supporting small businesses.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514">latest VZ news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514"><img loading="lazy" decoding="async" width="907" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157.png" alt="" class="wp-image-914632" style="width:698px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044824/image-157-768x709.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Nexstar Media Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXST#NASDAQ">NXST</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 4.27%</li>
<li>Benchmark analyst Daniel Kurnos maintained a Buy rating and raised the price target from $215 to $220 on May 9, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Wells Fargo analyst Steven Cahall maintained an Overweight rating and cut the price target from $216 to $200 on May 1, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 8, Nexstar Media Group reported better-than-expected first-quarter EPS results.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest NXST <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0514"><img loading="lazy" decoding="async" width="895" height="826" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158.png" alt="" class="wp-image-914635" style="width:671px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158.png 895w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14044903/image-158-768x709.png 768w" sizes="(max-width: 895px) 100vw, 895px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Dividends

Pre-Market Outlook

Markets

Trading Ideas

NXST

SSTK

Wall Street's Most Accurate Analysts Spotlight On 3 Tech And Telecom Stocks Delivering High-Dividend Yields

Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) affirms FY2025 sales outlook from $30.00 million to $30.00 million vs $40.20 million estimate.

Guidance

ALUR

Allurion Technologies Affirms FY2025 Sales Guidance of $30.00M vs $40.20M Est

WIIM

IXHL

Incannex Healthcare shares are trading higher after the company completed patient dosing in the Phase 2 portion of its Phase 2/3 RePOSA study of IHL-42X for obstructive sleep apnea.

Aprea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APRE#NASDAQ">APRE</a>) reported quarterly losses of $(0.66) per share. This is a 1.49 percent increase over losses of $(0.67) per share from the same period last year. The company reported $162.46 thousand in sales this quarter. This is a 57.31 percent decrease over sales of $380.57 thousand the same period last year.

APRE

Aprea Therapeutics Q1 EPS $(0.66) Up From $(0.67) YoY, Sales $162.46K Down From $380.57K YoY

Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.35) by 31.43 percent. This is a 85.37 percent increase over losses of $(1.64) per share from the same period last year.

BNTC

Benitec Biopharma Q3 EPS $(0.24) Beats $(0.35) Estimate

Kalaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLRS#NASDAQ">KLRS</a>) reported quarterly losses of $(2.52) per share which missed the analyst consensus estimate of $(1.17) by 115.38 percent. This is a 3.08 percent increase over losses of $(2.60) per share from the same period last year.

Earnings Misses

KLRS

Kalaris Therapeutics Q1 EPS $(2.52) Misses $(1.17) Estimate

<a href="https://www.globenewswire.com/Tracker?data=VFi76zOPFziMSR2L83lWTcD9X8IU9_hdqO5B40n9RLxP2qqmSR1JF-raa6_Ik_4j4qJiYG-antKeH0DlGMEp7fyTIIWVfSorVwAMNQP3aCc=">Enphase Energy, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that homeowners in all of New York's major investor-owned electric utility service territories who install Enphase IQ&#xAE; Batteries can now qualify to enroll in the NYSERDA New York Battery Incentive Program. Qualifying homeowners can receive an upfront payment of up to $6,250 through the program.
Homeowners in the Central Hudson, ConEd, NYSEG, National Grid, Orange and Rockland, and Rochester G&amp;E service areas could receive the upfront incentive. Homeowners in the ConEd territory of New York City and Westchester County are eligible for an upfront incentive of $250/kWh, capped at $6,250 per site. For example, customers who install five IQ&#xAE; Battery 5Ps could earn $6,250 upfront. Additionally, homeowners in all other utility territories are eligible for an upfront incentive of $200/kWh, capped at $5,000 per site. Homeowners who install five IQ Battery 5Ps can earn up to $5,000 upfront.

ENPH

Enphase Energy  Announces Homeowners In All Of New York's Major Investor-Owned Electric Utility Service Territories Who Install Enphase IQ Batteries Can Now Qualify To Enroll In The NYSERDA New York Battery Incentive Program

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Wednesday.
Shares of Alcon Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) fell sharply in today's pre-market trading as the company posted downbeat results for the first <a href="https://www.benzinga.com/quote/ALC">quarter on Tuesday</a>.
Alcon reported quarterly earnings of 73 cents per share which missed the analyst consensus estimate of 75 cents per share. The company reported quarterly sales of $2.45 billion which missed the analyst consensus estimate of $2.51 billion.
The company lowered its FY2025 earnings guidance, but raised its sales guidance.
Alcon shares dipped 5.5% to $87.79 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) shares dipped 16.7% to $6.11 in pre-market trading after Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) announced plans to sell some of its Aurora Innovation stake in a senior notes offering.</li>
<li>GRAIL, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>) shares fell 14.1% to $36.86 in pre-market trading after reporting weak quarterly sales.</li>
<li>American Eagle Outfitters, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) dipped 13.8% to $10.96 in pre-market trading after the company guided first-quarter revenue down and withdrew FY25 guidance.</li>
<li>Allot Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLT#NASDAQ">ALLT</a>) declined 8.1% to $7.79 in pre-market trading after gaining 8% on Tuesday.</li>
<li>XChange TEC.INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) dipped 7.5% to $2.33 in pre-market trading after jumping over 12% on Tuesday.</li>
<li>WEBTOON Entertainment Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBTN#NASDAQ">WBTN</a>) fell 7% to $9.17 in pre-market trading following first-quarter results.</li>
<li>Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) fell 3.2% to $37.77 in pre-market trading.</li>
<li>Pagaya Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGY#NASDAQ">PGY</a>) dipped 3.1% to $14.50 in pre-market trading.</li>
</ul>
Now Read This:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Movers

ALLT

GRAL

UBER

WBTN

Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Citigroup analyst Andrew Baum downgrades Merck &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) from Buy to Neutral and lowers the price target from $115 to $84.

Citigroup Downgrades Merck & Co to Neutral, Lowers Price Target to $84

Management

GRRR

Gorilla Technology Group Appoints Bruce Bower As CFO

Kala Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALA#NASDAQ">KALA</a>) reported quarterly losses of $(1.41) per share which beat the analyst consensus estimate of $(2.03) by 30.54 percent. This is a 66.43 percent increase over losses of $(4.20) per share from the same period last year.

KALA

Kala Bio Q1 EPS $(1.41) Beats $(2.03) Estimate

Indaptus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDP#NASDAQ">INDP</a>) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.18) by 77.78 percent. This is a 28.89 percent increase over losses of $(0.45) per share from the same period last year.

INDP

Indaptus Therapeutics Q1 EPS $(0.32) Misses $(0.18) Estimate

Biotech

General

Incannex Healthcare Completes Patient Dosing In Phase 2 Portion Of Phase 2/3 RePOSA Study Of IHL-42X In Obstructive Sleep Apnea

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Jefferies analyst Philippe Houchois downgraded the rating for Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) from Buy to Hold and maintained the price target of $16. Rivian Automotive shares closed at $14.87 on Tuesday. <a href="https://www.benzinga.com/quote/RIVN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Leerink Partners analyst Daina Graybosch downgraded iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) from Outperform to Market Perform and lowered the price target from $47 to $9. ITeos Therapeutics shares closed at $7.85 on Tuesday. <a href="https://www.benzinga.com/quote/ITOS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Benjamin Theurer downgraded Lavoro Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) from Overweight to Underweight and lowered the price target from $5 to $1.5. Lavoro shares closed at $2.44 on Tuesday. <a href="https://www.benzinga.com/quote/LVRO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Laura Champine downgraded Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) from Hold to Sell and announced a $35 price target. Wayfair shares closed at $39.01 on Tuesday. <a href="https://www.benzinga.com/quote/W/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying W stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="589" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-1024x589.png" alt="" class="wp-image-914889" style="width:648px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-1024x589.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160-768x442.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14080939/image-160.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

ITOS

LVRO

RIVN

This Wayfair Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday

AFCG

UPDATE: Advanced Flower Capital Q1 Adj. EPS $0.21 Misses $0.25 Estimate, Net Interest Income $6.64M Miss $7.61M Estimate

Press Releases

The Honest Company Announces CFO Retirement and Transition Plan in 2025

The Honest Company to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

The Honest Company CEO Carla Vernón Named to 2025 CNBC Changemakers: Women Transforming Business

The Honest Company Announces SVP of Supply Chain Appointment

The Honest Company Reports Fourth Quarter and Full Year 2024 Financial Results

Legal

Kuehn Law Encourages Investors of The Honest Company, Inc. to Contact Law Firm

The Honest Company Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The Honest Company to Report First Quarter Financial Results on May 7, 2025

The Honest Company Announces Appointment of Curtiss Bruce as Chief Financial Officer

The Honest Company Reports First Quarter 2025 Results

HNST

AXIL Brands

BellRing Brands

Coty

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Interparfums

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Entertainment

The Beauty Health Company - Class A Common Stock

Beauty Health

United-Guardian

Unilever

Upexi

Usana Health Sciences

Waldencast

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Comments

Honest Co

Honest Co (HNST) Options

Honest Co (NASDAQ:HNST) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL